Publications & Research

  1. Laird, JR, Katzen, BT, Scheinert, D, Lammer, J, Carpenter, J, Buchbinder, M, Dave, R, Ansel, G, Lansky, A, Cristea, E, Collins, TJ, Goldstein, J, Cao, AY, Jaff, MR. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.  J Endovasc Ther. 2012 Feb;19(1):1-9.
  2. Goldstein JA, Mishkel GJ. Choosing the correct therapeutic option for acute limb ischemia. Interventional Cardiology; 2011; 3(3), 381–389.
  3. Laird Jr., Katzan BT., Scheinert D., Lammer J., Carponter Jr., Buchbinder M., Dave R., Ansil G., Lausky A., Cristea E., Collins TJ., Goldstein, JA., Jaff MR,.  Nitinol Stent Implantation versus Balloon Angioplasty for Lesions in the superficial Femoral artery and Proximal Popliteal Artery and Proximal Popliteal Artery: Twelve month results from the RESILIENT Randomized Trial.  Circulation Cardiovascular Interventions.  2010, 3; 267-276.
  4. Mishkel G., Goswami N., Kolluri, R., Goldstein, JA. Deep Venous Interventions As A Cardiologist: A Programmatic Approach.  E-mail Thrombosis. 2009; Oct. 6.
  5. Goldstein JA., Kolluri R., Rocha-Singh, K., Technical considerations for renal artery stenting.  Vascular Disease Management. 2006; 3;3.
  6. Kolluri R., Goldstein, JA. Rocha-Singh K., Percutaneous Vascular Interventions In Renal Artery Diseases. Minerva Cardioangiologica.  2006; 54:95-107.
  7. Shah NR, Goldstein, JA., Balzer, DT., Lasala, JM., Moazami, N.,  Transcatheter   Repair of  Recurrent Post Infarct Ventricular Septal Defects.  Annals of Thoracic Surgery.  2005;80:1907-9.
  8. Casserly, IP., Goldstein, JA., Lasala, JM., Late Stent Thrombosis In The Non-Brachytherapy Population – A Real Phenomenon? Catheterization and Cardiovascular Intervention. 2003; 59(4)504-508.
  9. Kim, JH., Gutierrez, FR., Siegel, MJ., Goldstein, JA., Lasala, JM., Original report: radiologic findings of commonly used cardiac septal occluders with clinical correlation. Journal of Thoracic Imaging. 2003;18(3):183-9.
  10. Chrysant GS., Goldstein, JA., Casserly, IP., Rogers, JH., Kurz, HI., Thorstad, WL.,  Singh, J., Lasala, JM., Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Catheterization and Cardiovascular Intervention. 2003;59:251-254.
  11. Goldstein, JA., Casserly, IP., Balzer, DT., Lasala, JM., Transcatheter Closure Of Residual Post-Myocardial Infarction Ventricular Septal Defects Utilizing The Amplatzer Post-Infarction VSD Device: A Case Series. Catheterization and Cardiovascular Intervention. 2003;59:238-243.
  12. Goldstein, JA., Casserly, IP., Lasala, JM., Taniuchi, M., Aortocoronary Dissection Complicating a Percutaneous Coronary Dissection. Journal of Invasive Cardiology.  2003;15:89-92.
  13. Casserly, IP., Goldstein, JA., Rogers, JH., Lasala, JM., Paradoxical Embolization of A Fractured Guide Wire – Successful Retrieval From Left Atrium Using A Snare Device.  Catheterization and Cardiovascular Intervention. 2002; 57:34-38.
  14. Goldstein, JA., Beardslee, MA., XU, H., Sundt, TM., Lasala, JM., Infective Endocarditis Resulting From CardioSEAL Closure of a Patent Foramen Ovale.  Catheterization and Cardiovascular Intervention. 2002;55:217-220.
  15. Goldstein, JA. and Heinecke, JW., Mechanisms of Low-Density Lipoprotein Oxidation: Implications for Antioxidant Therapy. Journal of Vascular Medicine and Biology. 1994;5(5-6):212-222.
  16. Heinecke, JW., Li, W., Francis GA., Goldstein, JA., Tyrosyl Radical Generated By Myeloperoxidase Catalyzes the Oxidative Cross-Linking of Proteins.  Journal of Clinical Investigation.1993;91:2866-2972.
  17. Heinecke, JW., Li, W., Daehnke, HL., Goldstein, JA., Dityrosine, A Specific Marker  of Oxidation, is Synthesized By The Myeloperoxidase-Hydrogen Peroxide System of  Human Neutrophils and Macrophages. The Journal of Biological Chemistry. 1993;268(6):4069-4077.
  18. McGuinness, BF., Lipmann, R., Goldstein, JA., Nakinishi, K., Tomasz, M.,  Reductive Alkylation of DNA by Mitomycin a, a Mitomycin With High Redox Potential. Biochemistry. 1991;30(26):6444-6453.8.

ABSTRACTS:

  1. Rinder, MR., Goldstein, JA., Chrysant, GS., Rogers, J., Lasala, JM., Stereotactic
  2. Guidance Of Guidewires Is Safe And Efficient In A Swine Model For Coronary Intervention. American Journal of Cardiology. 90(Suppl 6A):124H.
  3. Goldstein, JA., Rogers, JH., Lasala, JM., Kurz, HI., Singh, J., Bach, RG., Rinder, MR, Taniuchi, M., Cutting balloon atherotomy is associated with decreased stent utilization. Catheterization and Cardiovascular Intervention. 2003;59:115-116.
  4. Goldstein, JA., Rogers, JH., Sarraf, KM., Kurz, HI., Singh, J., Bach, RG., Rinder, MR., Lasala, JM., Percutaneous closure of patent foramen ovale and atrial septal defects is associated with a low rate of recurrent events. Catheterization and Cardiovascular Intervention. 2003;59:136-137.
  5. Goldstein, JA., Rogers, JH., Casserly, IP., Lasala, JM., Kurz, HI., Singh, J., Bach,    RG., Rinder, MR., Taniuchi, M., Cutting balloon atherotomy is associated with decreased stent utilization. Journal of the American College of Cardiology. 2003;41(suppl. A): 55A.
  6. Casserly, IP., Goldstein, JA., Kurz, HI., Rinder, MR., Bach, RG., Singh, J., Lasala, JM.,  Taniuchi, M., Application of Intracoronary Brachytherapy Beyond Randomized Clinical Trials. Catheterization and Cardiovascular Intervention. 2002;56:120.
  7. Goldstein, JA., Casserly, IP., Kurz, HI., Rinder, MR., Bach, RG., Singh, J., Lasala, JM.,   Taniuchi, M., Cutting Balloon Atherotomy is Associated with Decreased Stent Utilization. Catheterization and Cardiovascular Intervention. 2002;56:130.
  8. Goldstein, JA., Casserly, IP., Sarraf, KM., Kurz, HI., Singh, J., Bach, RG., Rinder,     MR., Lasala, JM., Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defects Is Associated With A Low Rate Of Recurrent Events. American Journal of Cardiology. 2002;90(suppl 6A):135H.
  9. Casserly, IP., Goldstein, JA., Kurz, HI., Rinder, MR., Bach, RG., Singh, J., Lasala, JM., Taniuchi, M., Efficacy Of Intracoronary Brachytherapy For Instent Restenosis In An Open Population. American Journal of Cardiology. 90(Suppl 6A):9H.

BOOK CHAPTERS:

  1. Rocha-Singh K, Goswami NJ, Kolluri R, Goldstein J. Renal Artery Stenosis.  Textbook of Interventional Cardiology, 6th Edition, Editors E J. Topol and P S. Teirstein. Philadelphia: Elsevier Publishing; 2012: 538-547.
  2. Casserly IP, Goldstein JA. Endovascular therapy for femoropopliteal artery disease. Practical Peripheral Vascular Intervention. Editors Ivan P. Casserly, Ravish Sachar and Jay S. Yadav. Philadelphia: Lippincott Williams, and Wilkins; 2011:237-264.
  3. Goldstein JA, Kolluri R, Rocha-Singh, K. Subclavian and Upper Extremity Arterial Disease. Vascular Disease Diagnostic and Therapeutic Approaches. Editors Michael R. Jaff and Christopher J. White.  Minneapolis: Cardiotext Publishing; 2011: 53-72.
  4. Goldstein, JA., Casserly, IP., Rocha-Singh, K., Endovascular Therapy For Superficial femoral Arterial Disease.  In: Casserly IP., Sachar, R., Yadav, JS., Eds. Manual of Peripheral Vascular Intervention, Philadelphia: Lippincott Williams, and Wilkins; 2005:229-251.

CLINICAL RESEARCH:

  1. ACT 1: Asymptomatic Carotid Stenosis, Stenting versus Endarterectomy Trial
  2. Ardian: Renal Denervation in Patients with Refractory Hypertension, Pilot Study
  3. TAXUS ATLAS Direct Stent Study:  A multi-center, single-arm study of the TAXUS Liberte’ SR stent for the direct stenting treatment of patients with de novo coronary artery lesions.
  4. Atlas Long Lesion: A multi-center, single-arm study of the TAXUS Liberte’ SR Stent for the treatment of patients with long de novo coronary artery lesions.
  5. ATLAS SMALL VESSEL:  A multi-center, single-arm study of the TAXUS Liberte’-SR stent for the treatment of patients with de novo coronary artery lesions in small vessels.
  6. BRACCO IOP-117: A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Moderate Fall in eGRF Undergoing Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320.
  7. BRACCO IOP-116: A Phase lV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Normal eGFR Undergoing Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320.
  8. CHOICE: Carotid Stenting for High Surgical-Risk Patients; Evaluating Outcomes through the Collection of Clinical Evidence
  9. CIN REK: Evaluation of Sodium Bicarbonate to Reduce Contrast-Induced Nephropathy (CIN) in Subject with Advanced Kidney Disease (CKD) who are Undergoing Angiography.
  10. The Complete SE Iliac Registry.
  11. CONTINUUM: CONTINuous Infra-Inguinal Stenting Using the Bard LifeStent Vascular Stent Systems Protocol
  12. CORAL: Cardiovascular Outcomes in Renal Atherosclerotic Lesions:  Randomized and Multi-Center Two Group Clinical Trial To Assess The Best Treatment for Patients with High Blood Pressure and Renal Artery Stenosis:  Stenting with Anti-Hypertensive Medical Therapy, Compared to Medical Therapy Alone and Duplex Sub-study.
  13. CYPRESS:  A Prospective, Randomized, Multi-Center, Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER Sirolimus-eluting Coronary Stent (CYPHER Stent).
  14. CREST:  Carotid Revascularization Endarterectomy vs. Stent Trial
  15. Drug Eluting Stent Event Registry of Thrombosis – The National DES Thrombosis Registry
  16. DURABILITY II : The US Study for Evaluating Endovascular Treatments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By Using the Protégé Everlex Nitinol Stent System II.
  17. Durability Iliac Version 1.2
  18. The EXCITE ISR Trial: Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis.
  19. HERCULES:  Herculink Elite Cobalt Chromium Renal Stent Trial to Demonstrate Efficacy and Safety
  20. The IMPASSE Study: Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study.
  21. IMPROVE IT: A Multicenter, Double Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin/Simvastatin Tablet vs. Simvastatin Monotherapy in High Risk Subjects Presenting with Acute Coronary Syndrome.
  22. INTENSE: Iliac Artery Treatment with the Invatec scuba Cobalt Chromium Stent.
  23. Levant 2 Clinical Trial: A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment Femoropopliteal Arteries.
  24. Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self Expanding Stent System Study. Protocol No. FSS-0003.
  25. PARTNERS II: The Partners II Trial with Nested Registries: Placement of Aortic Transcatheter Valves Trail II
  26. Perseus SV: A Prospective Evaluation in a non-Randomized Trial of the Safety and Efficacy of the Use of the Taxus Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Nova Coronary Artery Lesions in Small Vessels
  27. Perseus WH: A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the Taxus Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Lesions
  28. PFAST CTO: Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusion (PFAST-CTOs) Protocol NO 200-012
  29. Pfizer Outcomes: Non-Interventional (NI) Drug Study Protocol: Impact of an Integrated Intervention Program on Adherence to Atorvastatin. Protocol No A2581184
  30. PFO Access: Patent Foramen Ovale Closure with the Amplatzer PFO Occluder in Patients with Recurrent Cryptogenic Stroke due to Presumed Paradoxical Embolism through a Patent Foramen Ovale who have Failed Conventional Drug Therapy.
  31. PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element) for the Treatment of up two De Novo Coronary Artery Lesions
  32. The Medtronic RESOLUTE US Clinical Trial: A Clinical Evaluation of the Medtronic Endeavor © Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25mm to 4.2mm.:
  33. RESPECT PFO: Randomized Evaluation of Recurrent Stroke comparing PFO Closure to Established Current Standard of Care Treatment.
  34. SAPPHIRE WW:  Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy.
  35. SCARLET DVT: A study of the efficacy of preventative dosing of fondaparinux sodium versus placebo for the prevention of venous thromboembolism in patients undergoing coronary bypass surgery receiving routine mechanical prophylaxis
  36. Seattle: Sub massive & Massive Pulmonary Embolism Treatment with Ultrasound Accelerated Thrombolysis Therapy
  37. SENSILASE: Validating Skin Perfusion Pressure (SPP) in Subjects with Significant PAD/CLI Utilizing the Sensilase System Protocol No.  250110
  38. SPIRIT III:  A clinical evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects with de novo Native Coronary Artery Lesions.
  39. SPIRIT PRIME: A Clinical Evaluation of the XIENCE PRIME and XIENCE PRIME LL Everolimus Eluting Coronary Stent System
  40. SPIRIT Small Vessel Registry: A Clinical Evaluation of the 2.25 mm XIENCE V Everolimus Eluting Coronary Stent System Protocol
  41. SYMPLICITY HTN-3: Renal Denervation in Patients with Uncontrolled Hypertension HTN-3
  42. Taxus Atlas WH: A multi-center, single-arm study of the Taxus Liberte’ stent for the treatment of patients with de novo coronary artery lesions.
  43. TriVascular AAA: A Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the TriVascular AAA Stent Graft System.
  44. TRYTON: A prospective, single blind, randomized, controlled study to evaluate the safety and effectiveness of the Tryton side brand stent used in conjunction with a drug eluting stent compared to side branch balloon angioplasty in conjunction with a drug-eluting stent in the treatment of de novo bifurcation lesions involving the main brand and side branch within the native coronary circulation
  45. VIBRANT- GORE VIABAHN Endoprosthesis versus Bare Nitinol Stent in the Treatment of Long Lesion Superficial Femoral Artery Occlusive Disease
  46. XIENCE: Xience V Everolimus Eluting Coronary Stent System USA Post-Approval Study
  47. The ZEN study:  The Medtronic Zotarolimus-eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males with Sub-optimal Response to PDE5
  48. ZILVER: Evaluation of the Zilver PTX Vascular Stent in the Above-the-Knee Femoropopliteal Artery.
  49. ZOMAXX: A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System as Compared to Taxus Express Paclitaxel – Eluting Stent in de novo Coronary Artery Lesions.
Share This